Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 10Relevant journals, 13Conferences, 11Workshops are presently dedicated exclusively to breathing disorder and about 286 articles are being published on medicine for tuberculosis.
Tuberculosis (tb) is an infection, primarily in the lungs (a pneumonia), caused by bacteria called mycobacterium tuberculosis. It was first isolated in 1882 by a German physician named Robert Koch who received the noble prize for this discovery. The most common symptoms and signs of tb are fatigue, fever, weight loss, coughing, hemoptysis, and night sweats. A new technology, light emitting-diode fluorescence microscopy (led-fm), a type of smear microscopy, is more sensitive than the standard ziehl-neelsen AFB stain to identify the bacteria. TB usually affects the lungs, but it can also affect the brain, kidneys, spine or other organ systems. TB can cause serious health problems, including death, if left untreated.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The scope of treatment of latent tuberculosis infection (LTBI) in the United States and Canada is unknown. Identifying the types of clinics that administer such treatment and patients who receive it could guide resource utilization and improve treatment initiation and completion. In 2013 the World Health Organisation (WHO) estimated that 3.5% of new cases and 20.5% of previously treated cases of TB were of MDR (Multi Drug Resistant) TB. There were an estimated 300,000 new cases of MDR TB among those cases of pulmonary TB that were reported to them.2 MDR TB is just one of the different types of drug resistant TB, and is TB that is resistant to the TB drugs isoniazid and rifampicin. It was also estimated that there were 480,000 new cases of MDR TB among the world’s 12 million prevalent cases of active TB. The number of prevalent cases of MDR-TB is important as it directly influences the active transmission of strains of MDR TB.3 (For more about TB incidence and prevalence see the TB statistics page.) There were also approximately 210,000 deaths from MDR-TB and more than half of these patients were in India, China and the Russian Federation.
Tuberculosis (tb) is an infection, primarily in the lungs (a pneumonia), caused by bacteria called mycobacterium tuberculosis. It was first isolated in 1882 by a German physician named Robert Koch who received the noble prize for this discovery. The most common symptoms and signs of tb are fatigue, fever, weight loss, coughing, hemoptysis, and night sweats. A new technology, light emitting-diode fluorescence microscopy (led-fm), a type of smear microscopy, is more sensitive than the standard ziehl-neelsen AFB stain to identify the bacteria. TB usually affects the lungs, but it can also affect the brain, kidneys, spine or other organ systems. TB can cause serious health problems, including death, if left untreated. According to the Centers for Disease Control and Prevention (CDC), fewer people in the U.S. have TB disease than in past years. However, despite a decrease in reported TB cases, the disease remains a serious threat, especially for people living with HIV/AIDS. That’s because TB infection and HIV infection can work together to make you very sick. Worldwide, TB is the leading cause of death among people living with HIV.TB is an issue for people living with HIV/AIDS in the U.S. because: It is estimated that about 4.2% of Americans (13 million individuals) are infected with TB bacteria, As of 2011, CDC estimated 6% of all TB cases and 10% of TB cases among people aged 25–44 occurred among people who were HIV-positive, Because of the serious health risks for co-infection with TB and HIV, the CDC recommends that all HIV-positive people should be tested for TB. Those who test positive for TB should begin treatment immediately. TB is primarily an airborne disease. When a person with active TB disease coughs, sneezes, speaks, or sings, TB germs spread through the air. These germs can float in the air for several hours. If you breathe in the air containing these TB germs, you can become infected. There are two types of TB infection latent (LTBI) and active. Symptoms of TB can vary from person to person. People who have LTBI will have no symptoms. People with active TB infection can experience persistent coughing (including coughing up blood), night sweats, fever, weight loss, chills, and fatigue. Treatment for TB can be as challenging as treatment for HIV. There are some risks involved, mainly because the treatments can cause liver damage in some people. If you have both HIV and TB, it is important to be closely monitored by a healthcare provider during your treatment to make sure you are not hurt by side effects from taking TB and HIV medicines together. Also, if you begin antibiotic therapy for TB, it’s important to take ALL your medication, on time and in the way your healthcare provider recommends. Like HIV, TB can become resistant to medications quickly if you miss doses of your meds. Multidrug-resistant TB (MDR TB) is TB that is resistant to at least two of the best anti-TB, Drug isoniazid and rifampin. MDR TB is extremely difficult to treat and can be fatal, extensively Drug-Resistant Tuberculosis (XDR TB) is resistant to the most powerful first-line and second-line drugs. Patients with XDR TB have fewer, less-effective treatment options and often have worse treatment outcomes. People living with HIV infection or with AIDS are at greater risk of dying of MDR TB and XDR TB.
Market Analysis:
The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
3rd Rhinology and Otology Conference
April 25-27, 2016 Dubai, UAE
4th Bacteriology and Infectious Diseases Conference
May 16-18, 2016 San Antonio, USA
2nd Respiratory and Pulmonary Medicine Conference
May 09-10, 2016 Chicago, USA
3rd COPD conference
July 11-12, 2016 Brisbane, Australia
2nd Infectious Diseases Conference:
August 25-27, 2016 Philadelphia, USA
Global Influenza Conferences
August 24-26, 2015 West Drayton, London, UK
4th Lung and Respiratory Care Conference
Aug-1-3, 2016 Manchester, UK
4th Immunology Conference
September 28-30, 2015 Houston, Texas, USA
Infectious Diseases and Diagnostic Microbiology Conference
Oct 3-5, 2016 Vancouver, Canada
2nd Flu Conference
November 17-19, 2016 San Francisco, USA
Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.
11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India
CHEST 2015 Conference:
October 24-28, Canada
46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015
20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015
5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney
Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore
Respiratory Diseases Conference:
Sep3-6, Guiyang City
Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel
16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA
European Respiratory Society International Congress:
26 September 2015, Amsterdam
Relevant Societies and Associations:
Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Vietnam Respiratory Society
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)
List of Companies and retreat centers:
GlaxoSmithKline
Pfizer
Sanofi-Aventis
AstraZeneca
Novartis
Roche
Wyeth
Merk & Co
Lilly
Boehringer Ingelheim
Johnson & Johnson
Schering Plough
Novo Nordisk
Bayer Schering
Abbott
Teva
Bristol-Myers Squibb
Mundi Int
Gilead Sciences
Servier
Edwards Lifesciences
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (U K ) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd
Advanced Healthcare Ltd
This page will be updated regularly.
This page was last updated on December 23, 2024
